William C. Rives, CFA

Portfolio Manager, Analyst

Mr. Rives is a Portfolio Manager of Putnam Research Fund and the Portfolio Manager of Putnam BioRevolution™ ETF, which focuses on companies at the intersection of technology and biology. In addition, Mr. Rives is an Analyst covering the health care and utilities sectors. He is responsible for conducting fundamental analysis, developing insights on material sustainability issues, assessing valuations, and making buy/sell recommendations for companies in the medical technology and life sciences industries and all companies in the utilities sector. Previously at Putnam, Mr. Rives served as an Equity Associate, covering multiple sectors. He has been in the investment industry since he joined Putnam in 2013.

ETFs

Putnam BioRevolution ETF

Mutual Funds

Fact sheet Annual Semi annual Compare
Research Fund
Overall Morningstar RatingTM among 1268 funds in the Large Blend category.
10-year Morningstar RatingTM among 867 funds in the Large Blend category.
5-year Morningstar RatingTM among 1169 funds in the Large Blend category.

More from the Equity team

Economic moats | Active investors seek wider moats

Economic moats, also called business moats, are competitive advantages that help a company maintain long-term profits and market share over competitors.

More »

You must be present to win: The outlook for large-cap growth stocks

Large-cap growth stocks delivered solid returns in the early months of 2023, and we remain optimistic about their prospects.

More »

How an active core strategy can benefit equity investors

An active core strategy backed by fundamental, sector-based research has demonstrated impressive long-term performance versus passive strategies.

More »

ESG: Hearing the signal above the noise

In our view, the best opportunities lie not at the extremes of ESG rhetoric, but at the heart of sustainability substance.

More »